health as it happens

Indian pharma industry to touch $130 bn by 2030: Dr Reddy's chairman

The Indian pharmaceutical industry is expected to grow almost by three times to about 130 billion US dollars by 2030

Topics Dr Reddy's | Pharma sector

The Indian pharmaceutical

industry is expected to grow almost by three times to about 130 billion US dollars by 2030, Chairman of Dr Reddy's Laboratories, K Satish Reddy said on Saturday.

"If you see, currently it's (pharmaceutical industry) about 42 billion dollars, half between the domestic sales, half between the exports.

We expect that it will grow almost by three times in the coming decade, reaching almost 120 to 130 billion dollars by 2030. Truly, we believe that we are poised for a tremendous growth in the coming decade," he predicted.

Reddy, Chairman of Boardof Governors of NIPER- Hyderabad, was virtually addressing the 9th Convocation of the institute.

The government's encouragement ('Atma Nirbhar Bharat' policy), a lot of reforms in the policy to incentivize the industry and thrust being given to innovation, among others, augur well for the industry, he said.

The Indian pharmaceutical industry worked continuously during the testing times of COVID-19 pandemic second wave to ensure the availability of life saving medicines.

During the period, the companies involved in making critical COVID-19 medicines responded very quickly ramping up production, he added.

He lauded the efforts of Union Chemicals and Fertilizers Minister Mansukh Mandaviya and the officials for providing a lot of interventionswhich helped the industry ramp up capacities.

Noting that the future of the Indian pharmaceutical industry is dependent on its ability to develop stronger capabilities in innovation and RD, Reddy said such capabilities which already exist, need to be strengthened further.

The Indian pharmaceutical sector can contribute to the country through the development of drugs for India-specific ailments which, unfortunately, do not get much global attention, he rued.

He also said digital technologies were heralding a big change in the whole spectrum of healthcare - the way patients are treated, the way medicines are supplied to patients and automation in manufacturing.

A whole host of opportunities got accelerated during the pandemic, he added.

Secretary of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, S Aparna spoke on efforts to attain self-sufficiency in APIs and others.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance. We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard .

Digital Editor